305 related articles for article (PubMed ID: 31990684)
1. Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis.
Maehara T; Kaneko N; Perugino CA; Mattoo H; Kers J; Allard-Chamard H; Mahajan VS; Liu H; Murphy SJ; Ghebremichael M; Fox D; Payne AS; Lafyatis R; Stone JH; Khanna D; Pillai S
J Clin Invest; 2020 May; 130(5):2451-2464. PubMed ID: 31990684
[TBL] [Abstract][Full Text] [Related]
2. Endothelial/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosis.
Manetti M; Neumann E; Müller A; Schmeiser T; Saar P; Milia AF; Endlicher E; Roeb E; Messerini L; Matucci-Cerinic M; Ibba-Manneschi L; Müller-Ladner U
Arthritis Rheum; 2008 Sep; 58(9):2866-73. PubMed ID: 18759276
[TBL] [Abstract][Full Text] [Related]
3. CD4
Perugino CA; Kaneko N; Maehara T; Mattoo H; Kers J; Allard-Chamard H; Mahajan VS; Liu H; Della-Torre E; Murphy SJH; Ghebremichael M; Wallace ZS; Bolster MB; Harvey LM; Mylvaganam G; Tuncay Y; Liang L; Montesi SB; Zhang X; Tinju A; Mochizuki K; Munemura R; Sakamoto M; Moriyama M; Nakamura S; Yosef N; Stone JH; Pillai S
J Allergy Clin Immunol; 2021 Jan; 147(1):368-382. PubMed ID: 32485263
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal analysis of T-cell receptor repertoires reveals persistence of antigen-driven CD4
Servaas NH; Zaaraoui-Boutahar F; Wichers CGK; Ottria A; Chouri E; Affandi AJ; Silva-Cardoso S; van der Kroef M; Carvalheiro T; van Wijk F; Radstake TRDJ; Andeweg AC; Pandit A
J Autoimmun; 2021 Feb; 117():102574. PubMed ID: 33307312
[TBL] [Abstract][Full Text] [Related]
5. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
Fuschiotti P; Medsger TA; Morel PA
Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
[TBL] [Abstract][Full Text] [Related]
6. Systemic sclerosis.
Asano Y
J Dermatol; 2018 Feb; 45(2):128-138. PubMed ID: 29226387
[TBL] [Abstract][Full Text] [Related]
7. New insights into CD4(+) T cell abnormalities in systemic sclerosis.
Liu M; Wu W; Sun X; Yang J; Xu J; Fu W; Li M
Cytokine Growth Factor Rev; 2016 Apr; 28():31-6. PubMed ID: 26724976
[TBL] [Abstract][Full Text] [Related]
8. Increased transendothelial migration of scleroderma lymphocytes.
Stummvoll GH; Aringer M; Grisar J; Steiner CW; Smolen JS; Knobler R; Graninger WB
Ann Rheum Dis; 2004 May; 63(5):569-74. PubMed ID: 15082489
[TBL] [Abstract][Full Text] [Related]
9. Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis.
Parel Y; Aurrand-Lions M; Scheja A; Dayer JM; Roosnek E; Chizzolini C
Arthritis Rheum; 2007 Oct; 56(10):3459-67. PubMed ID: 17907151
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-4 and interleukin-13 as possible therapeutic targets in systemic sclerosis.
Gasparini G; Cozzani E; Parodi A
Cytokine; 2020 Jan; 125():154799. PubMed ID: 31400638
[TBL] [Abstract][Full Text] [Related]
11. Increased CD226 Expression on CD8+ T Cells Is Associated with Upregulated Cytokine Production and Endothelial Cell Injury in Patients with Systemic Sclerosis.
Ayano M; Tsukamoto H; Kohno K; Ueda N; Tanaka A; Mitoma H; Akahoshi M; Arinobu Y; Niiro H; Horiuchi T; Akashi K
J Immunol; 2015 Aug; 195(3):892-900. PubMed ID: 26109642
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis.
Fuschiotti P; Larregina AT; Ho J; Feghali-Bostwick C; Medsger TA
Arthritis Rheum; 2013 Jan; 65(1):236-46. PubMed ID: 23001877
[TBL] [Abstract][Full Text] [Related]
13. T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.
Almeida I; Silva SV; Fonseca AR; Silva I; Vasconcelos C; Lima M
Clin Rev Allergy Immunol; 2015 Dec; 49(3):347-69. PubMed ID: 26445774
[TBL] [Abstract][Full Text] [Related]
14. T and B lymphocytes in fibrosis and systemic sclerosis.
Pillai S
Curr Opin Rheumatol; 2019 Nov; 31(6):576-581. PubMed ID: 31369432
[TBL] [Abstract][Full Text] [Related]
15. Role of cellular immunity in systemic sclerosis pathogenesis: update on CD4+T cells population studies.
Beşliu AN; Bănică LM; Lonescu R; Predeţeanu D; Stăvaru C; Marica CM; Chiţonu C; Pistol G; Stefănescu M; Matache C
Roum Arch Microbiol Immunol; 2009; 68(1):5-13. PubMed ID: 19507621
[TBL] [Abstract][Full Text] [Related]
16. Immune modulation during treatment of systemic sclerosis with plasmapheresis and immunosuppressive drugs.
Dau PC; Callahan JP
Clin Immunol Immunopathol; 1994 Feb; 70(2):159-65. PubMed ID: 8299231
[TBL] [Abstract][Full Text] [Related]
17. Induction of Inflammation and Fibrosis by Semaphorin 4A in Systemic Sclerosis.
Carvalheiro T; Affandi AJ; Malvar-Fernández B; Dullemond I; Cossu M; Ottria A; Mertens JS; Giovannone B; Bonte-Mineur F; Kok MR; Marut W; Reedquist KA; Radstake TR; García S
Arthritis Rheumatol; 2019 Oct; 71(10):1711-1722. PubMed ID: 31012544
[TBL] [Abstract][Full Text] [Related]
18. Increased microchimeric CD4+ T lymphocytes in peripheral blood from women with systemic sclerosis.
Artlett CM; Cox LA; Ramos RC; Dennis TN; Fortunato RA; Hummers LK; Jimenez SA; Smith JB
Clin Immunol; 2002 Jun; 103(3 Pt 1):303-8. PubMed ID: 12173305
[TBL] [Abstract][Full Text] [Related]
19. T cell repertoire in patients with stable scleroderma.
Tiev KP; Abriol J; Burland MC; Antonelli D; Klatzmann D; Cabane J; Boyer O
Clin Exp Immunol; 2005 Feb; 139(2):348-54. PubMed ID: 15654834
[TBL] [Abstract][Full Text] [Related]
20. Skin-Resident Effector Memory CD8
Li G; Larregina AT; Domsic RT; Stolz DB; Medsger TA; Lafyatis R; Fuschiotti P
J Invest Dermatol; 2017 May; 137(5):1042-1050. PubMed ID: 28012718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
